Literature DB >> 20435134

Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

Vivian Tseveleki1, Renee Rubio, Sotiris-Spyros Vamvakas, Joseph White, Era Taoufik, Edwige Petit, John Quackenbush, Lesley Probert.   

Abstract

The brain responds to injury and infection by activating innate defense and tissue repair mechanisms. Working upon the hypothesis that the brain defense response involves common genes and pathways across diverse pathologies, we analysed global gene expression in brain from mouse models representing three major central nervous system disorders, cerebral stroke, multiple sclerosis and Alzheimer's disease compared to normal brain using DNA microarray expression profiling. A comparison of dysregulated genes across disease models revealed common genes and pathways including key components of estrogen and TGF-beta signaling pathways that have been associated with neuroprotection as well as a neurodegeneration mediator, TRPM7. Further, for each disease model, we discovered collections of differentially expressed genes that provide novel insight into the individual pathology and its associated mechanisms. Our data provide a resource for exploring the complex molecular mechanisms that underlie brain neurodegeneration and a new approach for identifying generic and disease-specific targets for therapy. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435134      PMCID: PMC4205236          DOI: 10.1016/j.ygeno.2010.04.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  50 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia.

Authors:  M A Soriano; M Tessier; U Certa; R Gill
Journal:  J Cereb Blood Flow Metab       Date:  2000-07       Impact factor: 6.200

Review 3.  A concise guide to cDNA microarray analysis.

Authors:  P Hegde; R Qi; K Abernathy; C Gay; S Dharap; R Gaspard; J E Hughes; E Snesrud; N Lee; J Quackenbush
Journal:  Biotechniques       Date:  2000-09       Impact factor: 1.993

4.  TM4: a free, open-source system for microarray data management and analysis.

Authors:  A I Saeed; V Sharov; J White; J Li; W Liang; N Bhagabati; J Braisted; M Klapa; T Currier; M Thiagarajan; A Sturn; M Snuffin; A Rezantsev; D Popov; A Ryltsov; E Kostukovich; I Borisovsky; Z Liu; A Vinsavich; V Trush; J Quackenbush
Journal:  Biotechniques       Date:  2003-02       Impact factor: 1.993

5.  Comparison of microarray designs for class comparison and class discovery.

Authors:  K Dobbin; R Simon
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

6.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.

Authors:  Christopher Lock; Guy Hermans; Rosetta Pedotti; Andrea Brendolan; Eric Schadt; Hideki Garren; Annette Langer-Gould; Samuel Strober; Barbara Cannella; John Allard; Paul Klonowski; Angela Austin; Nagin Lad; Naftali Kaminski; Stephen J Galli; Jorge R Oksenberg; Cedric S Raine; Renu Heller; Lawrence Steinman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

7.  Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia.

Authors:  Yang Tang; Aigang Lu; Bruce J Aronow; Kenneth R Wagner; Frank R Sharp
Journal:  Eur J Neurosci       Date:  2002-06       Impact factor: 3.386

8.  Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.

Authors:  Debby Van Dam; Rudi D'Hooge; Matthias Staufenbiel; Chris Van Ginneken; Frans Van Meir; Peter P De Deyn
Journal:  Eur J Neurosci       Date:  2003-01       Impact factor: 3.386

9.  ArrayExpress--a public repository for microarray gene expression data at the EBI.

Authors:  Alvis Brazma; Helen Parkinson; Ugis Sarkans; Mohammadreza Shojatalab; Jaak Vilo; Niran Abeygunawardena; Ele Holloway; Misha Kapushesky; Patrick Kemmeren; Gonzalo Garcia Lara; Ahmet Oezcimen; Philippe Rocca-Serra; Susanna-Assunta Sansone
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

10.  Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia.

Authors:  Hong-Shuo Sun; Michael F Jackson; Loren J Martin; Karen Jansen; Lucy Teves; Hong Cui; Shigeki Kiyonaka; Yasuo Mori; Michael Jones; Joan P Forder; Todd E Golde; Beverley A Orser; John F Macdonald; Michael Tymianski
Journal:  Nat Neurosci       Date:  2009-09-06       Impact factor: 24.884

View more
  39 in total

1.  Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.

Authors:  Latt Latt Aung; Andrew Brooks; Steven A Greenberg; Michael L Rosenberg; Suhayl Dhib-Jalbut; Konstantin E Balashov
Journal:  J Neuroimmunol       Date:  2012-06-09       Impact factor: 3.478

2.  Activation of TRPM7 channels by small molecules under physiological conditions.

Authors:  T Hofmann; S Schäfer; M Linseisen; L Sytik; T Gudermann; V Chubanov
Journal:  Pflugers Arch       Date:  2014-03-15       Impact factor: 3.657

Review 3.  TRPM7.

Authors:  Andrea Fleig; Vladimir Chubanov
Journal:  Handb Exp Pharmacol       Date:  2014

4.  Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.

Authors:  V Chubanov; M Mederos y Schnitzler; M Meißner; S Schäfer; K Abstiens; T Hofmann; T Gudermann
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

5.  Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels.

Authors:  Susanna Zierler; Guangmin Yao; Zheng Zhang; W Cedric Kuo; Peter Pörzgen; Reinhold Penner; F David Horgen; Andrea Fleig
Journal:  J Biol Chem       Date:  2011-09-16       Impact factor: 5.157

6.  Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice.

Authors:  Maximilian Peters; Victoria Trembovler; Alexander Alexandrovich; Moshe Parnas; Lutz Birnbaumer; Baruch Minke; Esther Shohami
Journal:  J Neurotrauma       Date:  2012-11-16       Impact factor: 5.269

7.  The channel-kinase TRPM7 regulates phosphorylation of the translational factor eEF2 via eEF2-k.

Authors:  Anne-Laure Perraud; Xiaoyun Zhao; Alexey G Ryazanov; Carsten Schmitz
Journal:  Cell Signal       Date:  2010-11-25       Impact factor: 4.315

8.  Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.

Authors:  Sameh K Wasseff; Steven S Scherer
Journal:  Neurobiol Dis       Date:  2015-06-04       Impact factor: 5.996

9.  HDAC Inhibitor Sodium Butyrate-Mediated Epigenetic Regulation Enhances Neuroprotective Function of Microglia During Ischemic Stroke.

Authors:  Radhika Patnala; Thiruma V Arumugam; Neelima Gupta; S Thameem Dheen
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

10.  Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.

Authors:  Sebastian Schäfer; Silvia Ferioli; Thomas Hofmann; Susanna Zierler; Thomas Gudermann; Vladimir Chubanov
Journal:  Pflugers Arch       Date:  2015-12-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.